Related Experiment Video
Updated: Jul 10, 2026

11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Age-dependent mechanical and biochemical responses to glucagon
The American Journal of Physiology
|June 1, 1976
Summary
Glucagon affects adult heart muscle contraction but not fetal or newborn. This age-dependent response in heart function is linked to mature adenylate cyclase activity in adult hearts, absent in younger ones.
Area of Science:
- Cardiovascular Physiology
- Developmental Biology
- Biochemistry
Background:
- Glucagon is a hormone known to influence cardiac function.
- Understanding age-related differences in cardiac response to hormones is crucial for developmental and clinical insights.
Purpose of the Study:
- To investigate age-dependent effects of glucagon on myocardial mechanics and adenylate cyclase activity.
- To determine if fetal and newborn lambs respond to glucagon similarly to adult sheep.
Main Methods:
- Isolated ventricular myocardium and atrial strips from fetal, newborn, and adult sheep were used.
- Myocardial mechanics (force of contraction, frequency, tension) were measured.
- Adenylate cyclase and phosphodiesterase activities were assayed in myocardial homogenates and particulate fractions.
Main Results:
- Glucagon significantly increased contraction force and atrial activity in adults, but not in fetuses or newborns.
- Adenylate cyclase activity was stimulated by glucagon in adult myocardial particulate fractions (43% increase), but not in fetal ones.
- Phosphodiesterase activity was comparable across age groups and unaffected by glucagon.
Conclusions:
- Glucagon's effects on heart rate and contractility are age-dependent, mediated by adenylate cyclase.
- The lack of glucagon response in fetal and newborn lambs is attributed to immature glucagon receptor sites.
Related Concept Videos
Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Regulation of Blood Glucose
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

